ACE2 and COVID-19: Cleavage of IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1) was proven by proteases nsp3 and nsp5 in SARS-CoV-2 infected 293T-ACE2 cells, which was involved in the pathophysiology of COVID-19 [2].